Premier Alternatives

Centese

Omaha, NE · Founded 2015 · Privately Held (backing)

Developer of advanced post-operative surgical drainage designed to address expensive and frequent complications in open-heart or open-lung surgery. Centese is based in Omaha, NE and was founded in 2015. Its last reported valuation was $40.1 million in Nov 2023. It has raised $30.5 million across 3 recorded rounds; the latest was a $250,000 seed round in May 2026.

Last reported valuation
$40.1M
Oct 2026
Priced at
—
Total raised
$30.5M
Last round
Seed Round
May 2026

Centese key facts

as of Oct 2026
  • Developer of advanced post-operative surgical drainage designed to address expensive and frequent complications in open-heart or open-lung surgery.
  • Centese is valued at approximately $40.1M as of Oct 2026 (last reported valuation).
  • It has raised $30.5M across 3 recorded rounds; the latest was Seed Round ($250K) in May 2026.
  • Notable investors include US National Science Foundation, New York Angels, Invest Nebraska, Barshop Ventures, Accuryn — 17 tracked in total.
  • Centese has filed 2 Form Ds with the SEC since 2023, most recently May 2025 ($525K sold to 5 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$40.1M

Centese's last reported valuation, Nov 2023. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Centese with a free account
  • ·The complete investor list: 17 names
  • ·Watch Centese: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Centese funding rounds

3 rounds
May 2026Seed Round$250KSEC filing▮
May 2025Seed Round$525KSEC filing▮
Nov 2023Early Stage VC$15.1MSEC filing▮
Full funding history →

Centese valuation

Centese's last reported valuation was $40.1 million in Nov 2023. No priced round, secondary trade or fund mark has surfaced since.

How much has Centese raised?

Centese has raised $30.5 million across 3 recorded rounds since 2023. The largest was a $525,000 seed round in May 2025; the most recent was a $250,000 seed round in May 2026.

Centese has filed 2 Form Ds with the SEC since 2023, most recently in May 2025 ($525,000 sold to 5 investors).

Centese investors

17 investors are on record for Centese, including US National Science Foundation, New York Angels, Invest Nebraska and Barshop Ventures. The seed round in May 2026 drew 1 investor.

About Centese

Developer of advanced post-operative surgical drainage designed to address expensive and frequent complications in open-heart or open-lung surgery. The company's technology uses integrated sensors, algorithms, and a small battery-powered controller to monitor blood drainage and other fluids, enabling patients to recover quickly and providing clinicians with reliable data to make informed decisions.

Sector
Healthcare
HQ
Omaha, NE, United States
Founded
2015
Employees
17
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.